×
About 113 results

ALLMedicine™ Pediatric Rhabdomyosarcoma Center

Research & Reviews  43 results

Clinical significance of circulating tumor cells and cell-free DNA in pediatric rhabdom...
https://doi.org/10.1002/1878-0261.13197
Molecular Oncology; Tombolan L, Rossi E et. al.

Feb 26th, 2022 - Liquid biopsy analysis represents a powerful and noninvasive tool to uncover biomarkers for disseminated disease assessment and longitudinal monitoring of patients. Herein, we explored the value of circulating and disseminated tumor cells (CTC and...

D,L-Methadone enhances the cytotoxic activity of standard chemotherapeutic agents on pe...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114081
Journal of Cancer Research and Clinical Oncology; Urla C, Corteletti I et. al.

Feb 20th, 2022 - In advanced tumor stages, pediatric rhabdomyosarcoma (RMS) shows an intrinsic resistance to standard chemotherapy, which is associated with a dismal prognosis. Alternative therapeutic approaches and optimization of already existent treatment proto...

A Long-Term Follow-Up of Dental and Craniofacial Disturbances after Cancer Therapy in a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621981
International Journal of Environmental Research and Publi... Chang PC, Lin SY

Nov 28th, 2021 - Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and adolescents. A boy aged seven years and five months was diagnosed with stage three group III embryonal parameningeal RMS with intracranial extension. He received chemoth...

Fusion of the Paired Box 3 (PAX3) and Myocardin (MYOCD) Genes in Pediatric Rhabdomyosar...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569814
Cancer Genomics & Proteomics; Panagopoulos I, Gorunova L et. al.

Oct 27th, 2021 - Fusions of the paired box 3 gene (PAX3 in 2q36) with different partners have been reported in rhabdomyosarcomas and biphenotypic sinonasal sarcomas. We herein report the myocardin (MYOCD on 17p12) gene as a novel PAX3-fusion partner in a pediatric...

Proton RT for the Treatment of Pediatric Rhabdomyosarcoma
https://clinicaltrials.gov/ct2/show/NCT00592592

Oct 4th, 2021 - A special device is made for each participant to help them hold still during the treatment. This may be in the form of a mask or a custom made foam cradle depending on the area to be treated. Radiation treatments will be given once per day, 5 days...

see more →

Clinicaltrials.gov  1 results

Proton RT for the Treatment of Pediatric Rhabdomyosarcoma
https://clinicaltrials.gov/ct2/show/NCT00592592

Oct 4th, 2021 - A special device is made for each participant to help them hold still during the treatment. This may be in the form of a mask or a custom made foam cradle depending on the area to be treated. Radiation treatments will be given once per day, 5 days...

see more →

News  1 results

OncoBriefs: Hormonal Link to CRC, Proton RT, PSA Recurrence
https://www.medpagetoday.com/hematologyoncology/coloncancer/48242

Oct 25th, 2014 - Action Points Large reductions in a regulatory hormone were found in 85% of tissue specimens from patients with colorectal cancer, suggesting a potential new therapeutic target. In another study, almost a third of older men with PSA recurrence aft...

see more →